Ambrx, Inc. Lands $10,000,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3d24f069-296b-4571-8ef8-276cded01ebd&Preview=1
-
Date
4/1/2009
-
Company Name
Ambrx, Inc.
-
Mailing Address
10975 North Torrey Pines Road La Jolla, CA 92037
-
Company Description
Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics.
-
Website
http://www.ambrx.com
-
Transaction Type
Venture Equity
-
Transaction Amount
$10,000,000
-
Transaction Round
Undisclosed
-
Proceeds Purposes
Proceeds purposes were not disclosed.
-
M&A Terms
-
Venture Investor
5AM Ventures
-
Venture Investor
Aravis Ventures
-
Venture Investor
CMEA Ventures
-
Venture Investor
Maverick Capital
-
Venture Investor
Versant Ventures
-
Venture Investor
Tavistock Life Sciences
Add Your Thoughts
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
